Dipentylone
Dipentylone (also known as Dimethylpentylone) is a substituted cathinone derivative with stimulant effects,[1] which has been sold as a designer drug,[2][3] first detected in Sweden in 2014.[4]
![]()  | |
| Legal status | |
|---|---|
| Legal status | 
  | 
| Identifiers | |
  | |
| CAS Number | 
  | 
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C14H19NO3 | 
| Molar mass | 249.310 g·mol−1 | 
| 3D model (JSmol) | |
  | |
  | |
See also
    
    
References
    
- Gatch MB, Shetty RA, Sumien N, Forster MJ (July 2021). "Behavioral effects of four novel synthetic cathinone analogs in rodents". Addiction Biology. 26 (4): e12987. doi:10.1111/adb.12987. PMID 33155384.
 - Celma A, Sancho JV, Salgueiro-González N, Castiglioni S, Zuccato E, Hernández F, Bijlsma L (September 2019). "Simultaneous determination of new psychoactive substances and illicit drugs in sewage: Potential of micro-liquid chromatography tandem mass spectrometry in wastewater-based epidemiology". Journal of Chromatography A. 1602: 300–309. doi:10.1016/j.chroma.2019.05.051. PMID 31171357.
 - "Police and drug agency issue strong warning after new drug detected in Dunedin". New Zealand Herald. 8 December 2021.
 - "Europol 2014 Annual Report on the implementation of Council Decision" (PDF). European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) – Europol. 2005/387/JHA.
 
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
